Atrium Therapeutics, Inc. Common Stock (RNA)
ETFs that hold Atrium Therapeutics, Inc. Common Stock (RNA)
Atrium Therapeutics, Inc. Common Stock is held by 4 ETFs tracked in our database. The largest position is held by IWM (0.16%), a small-cap fund. The remaining funds hold it at 0.02% or less. The largest holders are mostly small-cap funds.
ETFs holding Atrium Therapeutics, Inc. Common Stock (RNA) in our database, ranked by portfolio weight.
Symbol | Name | Weight |
|---|---|---|
| IWM | iShares Russell 2000 ETF | 0.16% |
| SCHB | Schwab US Broad Market ETF | 0.02% |
| IWO | iShares Russell 2000 Growth ETF | 0.01% |
| IWN | iShares Russell 2000 Value ETF | <0.01% |
Which ETFs hold Atrium Therapeutics, Inc. Common Stock (RNA)?
The ETFs with the largest positions in Atrium Therapeutics, Inc. Common Stock (RNA) are: iShares Russell 2000 ETF (IWM, 0.16%); Schwab US Broad Market ETF (SCHB, 0.02%); iShares Russell 2000 Growth ETF (IWO, 0.01%); iShares Russell 2000 Value ETF (IWN, <0.01%). The full list, ranked by weight, is in the table.
How many ETFs hold Atrium Therapeutics, Inc. Common Stock (RNA)?
Atrium Therapeutics, Inc. Common Stock (RNA) is held by 4 ETFs tracked in our database. The largest position is in IWM, where it makes up 0.16% of the fund's assets.
What does the ETF weight mean?
The weight is the share of a fund's assets invested in the stock. It shows how much passive index-fund ownership the stock has and where it carries the most influence. IWM holds Atrium Therapeutics, Inc. Common Stock (RNA) at 0.16%, and the simple average weight across the 4 funds is 0.05%.